EDITORIAL SECTION
-
STRATEGY
Smarter Pharma
Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products
-
RESEARCH DEVELOPMENT
Cytiva Laboratory capsule filters
Our singleuse selfcontained filtration solution
-
CLINICAL TRIALS
Why Clinical Trials Need Digital Endpoints
According Citeline the average success rate for bringing a Phase candidate to market has dropped to an alltime low of just
-
MANUFACTURING
Ensuring Quality and Compliance in Biopharma
Ensuring quality and regulatory compliance in the biopharmaceutical industry is critical to safeguarding product safety and efficacy
-
Information Technology
The Cost of Bad Data
Modern pharmaceutical research generates an unprecedented volume of information Data from genomic sequencing
-
Biopharma
Reimagining Global Biomanufacturing Capacity with Continuous and Modular Systems
Biotechnology is fueling the ongoing expansion of the global market for a broad array of goods
-
EXPERT Talk
Navigating the AI Transformation in Healthcare
Real Chemistrys expansion into Zurich is part of our broader objective to help clients by scaling internationally while maintaining a local mindset We are bringing our connected capabilities to one of Europes most influential hotspots sitting at the intersection of science innovation and investment This convergence is ideal for collaboration
Advisory Board
KNOWLEDGE BANK
-
Articles
Trapicolast Emerges as a First-In-Class Response to Drug Resistance: The Weakest
Malaria remains one of the worlds most persistent infectious diseases Each year it infects hundreds of millions and causes more than half a million deaths with subSaharan Africa bearing the overwhelming burden Children under five account for most fatalities highlighting malarias deep inequity
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
In the dynamic field of biological sciences the fusion of bioinformatics and computational biology has catalyzed a paradigm shift in genome analysis This synergistic collaboration harnesses cuttingedge computational tools statistical models
Fundamentals of Pharmaceutical Formulation Development
The process of changing an active drug substance into a safe and effective drug is much more complicated than it seems at first sight The core of this undertaking is pharmaceutical formulation development a science and strategic field that unites the pursuit of striking a scientific breakthrough and patient care Even the most promising drug molecule would not confer therapeutic benefits without be...
Regulatory Challenges in Clinical Testing for New Pharmaceuticals
The clinical testing is a stage where the new pharmaceutical products are a trial on human beings or patients The aims of clinical trials are to assess the effectivenesssafetytolerability or intolerance of new drug in man Generally clinical trials are conducted in phases each phase has different questions regarding the drug
Role of QSAR in filling in the gaps of CoVID-19 Therapeutics
Since initial reports from Wuhan China in December and the subsequent declaration of a global pandemic by the WHO in March CoVID has precipitated the greatest health crisis in modern history While exposing fundamental weaknesses in healthcare systems across the globe this tragedy has also been an opportunity for scientists and researchers in different fields to collaborate and produce solutions...
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Over the past decade pharmaceutical organisations have made strong progress in both digitising and digitalising quality operations Systems such as laboratory information management systems LIMS manufacturing execution systems MES and electronic quality management systems eQMS have strengthened traceability embedded workflows and enabled real time visibility across quality processes
-
Techno Trends
FDA Grants Breakthrough Therapy Designation to Calico's Fosigotifator
Calico Life Sciences LLC has announced that the US Food and Drug Administration FDA has granted Breakthrough Therapy Designation to fosigotifator for the treatment of Vanishing White Matter disease a rare and progressive neurological disorder with no approved therapies
-
Projects
Johnson & Johnson Invests $1B to Expand U.S. Vision Manufacturing & Distribution
Johnson Johnson has announced an investment of more than billion to expand its Vision manufacturing operations in Jacksonville Florida The project is designed to increase domestic manufacturing packaging and distribution capacity for the company
-
Research Insights
A genomic-led strategy to anticipate drug safety effects
Safetyrelated issues account for approximately of failures in new drug discovery programs On top of that many are discovered during postmarketing surveillance
-
whitepaper
Placing the Right Bets: Defining Tailored Investment Strategies for Pharma Launch
Pharmaceutical launches have become significantly harder to execute successfully As IQVIAs new white paper highlights median six month cumulative sales for innovative launches have declined by compared with pre levels reflecting shrinking market opportunities
TOP ARTICLES
-
1
The Synergy of Bioinformatics and Computational Biology in Genome Analysis
Kate Williamson
The synergy of bioinformatics and computational biology revolutionizes genome analysis, decoding DNA sequences, gene expression patterns, protein structures, and evolutionary relationships. It empower...
-
2
Fundamentals of Pharmaceutical Formulation Development
Kate Williamson
Drug innovation is a principal responsibility of pharmaceutical formulation development that provides the drug with stability, bioavailability, and adherence in the patients. Researchers can make mole...
-
3
Regulatory Challenges in Clinical Testing for New Pharmaceuticals
Kate Williamson
The development of new drugs is quite a protracted process, which goes through some stages, ensuring that therapeutic products would not be toxic to patients and would adequately provide agreed-upon t...
-
4
Role of QSAR in filling in the gaps of CoVID-19 Therapeutics
Smriti Sharma Bhatia
Yousuf Khan
Kunika Saini
QSAR modelling has been used extensively as an efficient method in the process of drug development against CoVID-19. The rapid spread and devastating impact of this viral disease across the globe requ...
-
5
From Visibility to Decision Readiness: The Next Phase of Quality Maturity in Pharma
Kavita Vengurlekar
Pharma companies can now see quality issues much earlier, thanks to digital systems. But faster visibility hasn’t always meant faster decisions. This article explains why the next step in qualit...
press releases Read more...
Lundbeck announces last patient randomized in DEEp OCEAN, a large Phase III trial in developmental and epileptic encephalopathies (DEEs)
H Lundbeck AS Lundbeck today announced that the last patient has been randomized in DEEp OCEAN NCT a global Phase III clinical trial evaluating the efficacy safety and tolerability of bexicaserin
Amneal Expands Iohexol Injection Portfolio with U.S. FDA Approval of Additional Strengths and Presentations
Amneal Pharmaceuticals Inc today announced that it has received US Food and Drug Administration FDA approval for additional strengths and vial presentations of iohexol injection mg iodinemL in mL mL
Aqemia and Sanofi Expand Their Research Collaboration
Aqemia the drug invention company combining generative AI and quantuminspired physics to invent small molecule drugs today announced the expansion of its multiyear research collaboration with the global pharmaceutical company
AI, Forecasting, Insights and Analytics for Smarter Decisions in Pharma
Forecasting insights and analytics is a strategic decisionmaking function within global product strategy and commercial departments in pharmaceutical companies Unlike operational or salesfocused functions
Events Read more...
20 - 22
Jul 20266th mRNA-Based Therapeutics Summit
The Westin Boston Seaport Dist...
20 - 22
Jul 2026Liquid Biopsy for Precision Oncology Summit
Boston, MA, USA
24 - 25
Jul 2026Cardiovascular Medicine Pharmacology 2026
Paris, France
26 - 30
Jul 2026ADLM 2026
Anaheim, CA USA
27 - 28
Jul 2026Pharmacovigilance & Drug Safety 2026
Rome, Italy
27 - 28
Jul 2026Pharmacology 2026
Rome, Italy
27 - 28
Jul 2026PharmaSci Innovations 2026
Rome, Italy
28 - 30
Jul 20265th In Vivo Cell & Gene Summit 2026
500 Commonwealth Avenue, Bosto...
LATEST NEWS Read more...
Dyne Therapeutics’ BLA for Z-Rostudirsen Accepted by FDA for Review in Exon 51 Duchenne Muscular Dystrophy
Dyne Therapeutics has announced that the US Food and Drug Administration FDA has accepted its Biologics License Application BLA for zeleciment rostudirsen zrostudirsen also known as DYNE
European Commission approves JASCAYD® for IPF and PPF treatment in the EU
The European Commission EC has granted marketing authorisation for JASCAYD nerandomilast for the treatment of adults with idiopathic pulmonary fibrosis IPF and progressive pulmonary fibrosis PPF Boehringer Ingelheim announced
ThalassaX Therapeutics doses first patient in U.S. Phase I trial of CS231295
ThalassaX Therapeutics United States Ltd has announced that the first patient has been dosed in its US Phase I clinical trial of CS a brainpenetrant Aurora B kinase selective inhibitor developed
Boehringer Ingelheim Advances Obesity Pipeline with Phase II Trial of Triple Receptor Agonist
Boehringer Ingelheim has started a Phase II clinical trial of BI an investigational triple GLPGIPNPY receptor agonist for the treatment of people with obesity and overweight
Umoja Biopharma Receives FDA Clearance to Begin Clinical Trial of UB-VV400 In Vivo CAR T Cell Therapy
Umoja Biopharma has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for UBVV a CDdirected in vivo CAR T cell therapy for adults
Sinopia Biosciences Publishes Preclinical Study Supporting SB-0110 for Parkinson's Disease
Sinopia Biosciences has published preclinical research in Science Translational Medicine highlighting a new approach to treating Parkinsons disease The study supports the development of SB




